SpartaLabs
June 17, 2026
Tirzepatide: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies tirzepatide for research applications. Educational reference.
tirzepatidesourcingquality
Research library
Peptide research library
Published literature, mechanisms, and protocols — organized by compound. Educational reference, not medical advice.
All articles
SpartaLabs
June 17, 2026
Tirzepatide: Published Research Summary
A research-library summary of published peer-reviewed studies on tirzepatide — from preclinical characterization through the SURPASS and SURMOUNT phase 3 programs. Educational reference.
tirzepatideglp-1gip
SpartaLabs
June 17, 2026
Tirzepatide: A Research Overview
A research-library overview of tirzepatide — chemistry, dual incretin classification, pharmacological properties, and regulatory history. Educational reference.
tirzepatideglp-1gip
SpartaLabs
June 17, 2026
Tirzepatide: Mechanism of Action
A research-library summary of tirzepatide's reported mechanism of action — dual incretin receptor targets, biased agonism, and downstream signaling from published studies. Educational reference.
tirzepatideglp-1gip
SpartaLabs
June 17, 2026
Tirzepatide: Discovery and Regulatory History
A research-library timeline of tirzepatide's scientific origins — from incretin discovery through a clinical development program that produced two landmark FDA approvals. Educational reference.
tirzepatideglp-1gip
SpartaLabs
June 17, 2026
Thymosin Alpha-1: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies Thymosin Alpha-1 for research applications. Educational reference.
thymosin-alpha-1sourcingquality
SpartaLabs
June 17, 2026
Thymosin Alpha-1: Published Research
A bibliographic summary of published clinical and preclinical research on Thymosin Alpha-1 — covering hepatitis B, oncology, COVID-19 cohort data, and emerging immuno-oncology directions. Educational reference.
thymosin-alpha-1thymic-peptideclinical-research
SpartaLabs
June 17, 2026
Thymosin Alpha-1: A Research Overview
A research-library overview of Thymosin Alpha-1 (Tα1 / Zadaxin) — chemistry, pharmacological classification, regulatory status, and six decades of discovery history at George Washington University. Educational reference.
thymosin-alpha-1thymic-peptideimmunomodulatory-peptide
SpartaLabs
June 17, 2026
Thymosin Alpha-1: Mechanism of Action
A research-library summary of the reported molecular pharmacology of Thymosin Alpha-1 — TLR9/TLR2 signaling in dendritic cell subsets, IDO pathway activation, and downstream interferon effects characterized in published literature. Educational reference.
thymosin-alpha-1tlr9dendritic-cell
SpartaLabs
June 17, 2026
Thymosin Alpha-1: Discovery and Regulatory History
A research-library account of the discovery, early characterization, and regulatory milestones of Thymosin Alpha-1 — from Allan Goldstein's thymus research through Zadaxin's international approvals and active regulatory engagement. Educational reference.
thymosin-alpha-1thymic-peptidezadaxin
SpartaLabs
June 17, 2026
Tesamorelin: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies tesamorelin for research applications. Educational reference.
tesamorelinsourcingquality
SpartaLabs
June 17, 2026
Tesamorelin: Published Research
A bibliographic summary of published clinical and pharmacological research on tesamorelin — pivotal trials, GH-axis pharmacodynamics, hepatic outcomes, and active research frontiers. Educational reference.
tesamorelinclinical-trialsghrh-analog
SpartaLabs
June 17, 2026
Tesamorelin: A Research Overview
A research-library overview of tesamorelin — chemistry, GHRH-analog pharmacology, FDA approval history, and discovery lineage of this synthetic peptide. Educational reference.
tesamorelinghrh-analoggrowth-hormone-axis
SpartaLabs
June 17, 2026
Tesamorelin Mechanism of Action
A research-focused examination of tesamorelin's reported mechanism — GHRH receptor binding, GH-axis signaling cascade, and pharmacological basis for its activity as a GHRH analog. Educational reference.
tesamorelinghrh-receptorgh-axis
SpartaLabs
June 17, 2026
Tesamorelin: Discovery and Regulatory History
A chronological account of tesamorelin's development — from the isolation of endogenous GHRH in 1982 through Theratechnologies' clinical program, FDA approval of Egrifta in 2010, and continued research through 2025. Educational reference.
tesamorelinghrh-analogregulatory-history
SpartaLabs
June 17, 2026
TB-500: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies TB-500 (Ac-LKKTETQ) for research applications. Educational reference.
tb-500sourcingquality
SpartaLabs
June 17, 2026
TB-500: Published Research
A bibliographic review of peer-reviewed studies on TB-500 (Ac-LKKTETQ) and parent peptide thymosin beta-4, covering actin biology, corneal wound models, cardiac research, and the active frontiers in clinical investigation. Educational reference.
tb-500thymosin-beta-4actin-binding
SpartaLabs
June 17, 2026
TB-500: A Research Overview
A research-library overview of TB-500 (Ac-LKKTETQ), the synthetic actin-binding peptide derived from the central active region of thymosin beta-4, covering chemistry, classification, and regulatory context. Educational reference.
tb-500thymosin-beta-4actin-binding
SpartaLabs
June 17, 2026
TB-500 Mechanism of Action: Published Research
A review of the reported molecular mechanisms of TB-500 (Ac-LKKTETQ) and full-length thymosin beta-4, including actin sequestration, the WH2 module, cell migration, and downstream signaling pathways described in peer-reviewed literature. Educational reference.
tb-500thymosin-beta-4actin-sequestration
SpartaLabs
June 17, 2026
TB-500: Discovery and Regulatory History
A timeline of the discovery of thymosin beta-4, the characterization of its LKKTETQ active fragment, the emergence of the synthetic TB-500 research compound, and its regulatory and anti-doping milestones. Educational reference.
tb-500thymosin-beta-4peptide-history
SpartaLabs
June 17, 2026
SS-31 (Elamipretide): Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies SS-31 (elamipretide) for research applications. Educational reference.
ss-31sourcingquality
SpartaLabs
June 17, 2026
SS-31 (Elamipretide): Published Research
A research-library summary of published preclinical and clinical studies on SS-31 (elamipretide), covering methodology, reported findings, and areas of ongoing investigation. Educational reference.
ss-31elamipretideclinical-trials
SpartaLabs
June 17, 2026
SS-31 (Elamipretide): A Research Overview
A research-library overview of SS-31 (elamipretide / Bendavia) — chemistry, pharmacological classification, cardiolipin-targeting mechanism, and regulatory history. Educational reference.
ss-31elamipretidemitochondria-targeted
SpartaLabs
June 17, 2026
SS-31 (Elamipretide) Mechanism of Action
A research-library summary of the reported molecular mechanism of SS-31 (elamipretide) — cardiolipin binding, cytochrome c modulation, and electron transport chain interactions. Educational reference.
ss-31elamipretidemechanism-of-action
SpartaLabs
June 17, 2026
SS-31 (Elamipretide): Discovery and Regulatory History
A research-library timeline of SS-31 (elamipretide) — from its serendipitous discovery at Cornell through Stealth BioTherapeutics' clinical development and FDA accelerated approval. Educational reference.
ss-31elamipretidediscovery-history
SpartaLabs
June 17, 2026
Semax: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies Semax for research applications. Educational reference.
semaxsourcingquality
SpartaLabs
June 17, 2026
Semax: Published Research
A bibliographic summary of published peer-reviewed research on Semax — covering in vitro, rodent model, and transcriptomic studies across melanocortin pharmacology, BDNF/NGF neurotrophin signaling, and ischemia models. Educational reference.
semaxmelanocortinbdnf
SpartaLabs
June 17, 2026
Semax: A Research Overview
A research-library overview of Semax — ACTH(4-10) analog chemistry, melanocortin/BDNF pharmacology, and the compound's place in the published neuropeptide literature. Educational reference.
semaxmelanocortinacth-analog
SpartaLabs
June 17, 2026
Semax Mechanism of Action
A research-library review of the reported molecular mechanisms of Semax — melanocortin receptor pharmacology, BDNF and NGF neurotrophin pathway interactions, and monoaminergic effects documented in primary literature. Educational reference.
semaxmelanocortinbdnf
SpartaLabs
June 17, 2026
Semax: Discovery and Regulatory History
A research-library account of Semax's discovery in Soviet-era academic research, its development by the Institute of Molecular Genetics, Russian regulatory milestones, and current research landscape. Educational reference.
semaxmelanocortinacth-analog
SpartaLabs
June 17, 2026
Semaglutide: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies semaglutide for research applications. Educational reference.
semaglutidesourcingquality
SpartaLabs
June 17, 2026
Semaglutide: Published Research
A bibliographic summary of peer-reviewed clinical research on semaglutide, covering the SUSTAIN, PIONEER, STEP, and SELECT trial programs, with methodology descriptions and reported findings attributed to their primary sources.
semaglutideglp-1-receptor-agonistclinical-trials
SpartaLabs
June 17, 2026
Semaglutide: A Research Overview
An educational reference covering the chemistry, pharmacological classification, and regulatory history of semaglutide, a long-acting glucagon-like peptide-1 receptor agonist developed at Novo Nordisk.
semaglutideglp-1-receptor-agonistincretin-mimetic
SpartaLabs
June 17, 2026
Semaglutide: Mechanism of Action
A research reference describing the reported molecular interactions, receptor-signaling pathways, and downstream pharmacological effects of semaglutide at the glucagon-like peptide-1 receptor, as characterized in published literature.
semaglutideglp-1-receptor-agonistmechanism-of-action
SpartaLabs
June 17, 2026
Semaglutide: Discovery and Regulatory History
A chronological account of the scientific discoveries, structural engineering milestones, and regulatory events that led from the identification of glucagon-like peptide-1 in the 1980s to the development and regulatory authorization of semaglutide across multiple indications.
semaglutideglp-1-receptor-agonistdrug-discovery-history
SpartaLabs
June 17, 2026
Selank: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies Selank for research applications. Educational reference.
selanksourcingquality
SpartaLabs
June 17, 2026
Selank: Published Research
An educational reference summarizing peer-reviewed studies on Selank, a synthetic tuftsin-derived heptapeptide, across preclinical behavioral pharmacology, molecular biology, and clinical investigation.
selanktuftsin-analoggabaergic-research
SpartaLabs
June 17, 2026
Selank: A Research Overview
An educational reference covering the chemistry, pharmacological classification, regulatory status, and discovery history of Selank, a synthetic heptapeptide with characterized GABAergic and enkephalinergic activity.
selanktuftsin-analoggabaergic-research
SpartaLabs
June 17, 2026
Selank Mechanism of Action
An educational reference summarizing published pharmacological mechanisms proposed for Selank, including GABAergic gene modulation, enkephalinase inhibition, and BDNF regulation in preclinical models.
selankgabaergic-researchenkephalin-pharmacology
SpartaLabs
June 17, 2026
Selank: Discovery and Regulatory History
An educational reference tracing the discovery, preclinical development, clinical investigation, and regulatory registration of Selank, a synthetic tuftsin-derived heptapeptide developed at the Institute of Molecular Genetics in Moscow.
selanktuftsin-analogneuropeptide-pharmacology
SpartaLabs
June 17, 2026
Retatrutide: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies retatrutide for research applications. Educational reference.
retatrutidesourcingquality
SpartaLabs
June 17, 2026
Retatrutide: Published Research Summary
A research-library summary of published peer-reviewed studies on retatrutide (LY3437943) across preclinical characterization, phase 1, phase 2, and phase 3 clinical trial settings. Educational reference.
retatrutideglp-1gip
SpartaLabs
June 17, 2026
Retatrutide: A Research Overview
A research-library overview of retatrutide (LY3437943) — chemistry, pharmacological classification as a triple receptor agonist, and regulatory status as an investigational compound. Educational reference.
retatrutideglp-1gip
SpartaLabs
June 17, 2026
Retatrutide Mechanism of Action
A research-library summary of the reported receptor pharmacology and signaling mechanisms of retatrutide (LY3437943), an investigational triple GIP, GLP-1, and glucagon receptor agonist. Educational reference.
retatrutideglp-1gip
SpartaLabs
June 17, 2026
Retatrutide: Discovery and Regulatory History
A research-library account of retatrutide's (LY3437943) discovery period, scientific lineage across three receptor systems, clinical development milestones, and current investigational status. Educational reference.
retatrutideglp-1gip
SpartaLabs
June 17, 2026
PT-141 (Bremelanotide): Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies PT-141 (bremelanotide) for research applications. Educational reference.
pt-141sourcingquality
SpartaLabs
June 17, 2026
PT-141 (Bremelanotide): Published Research
A research-library summary of published clinical and preclinical studies on bremelanotide (PT-141), covering phase 1 through phase 3 trials, neuroimaging findings, and areas of ongoing investigation. Educational reference.
pt-141bremelanotidemelanocortin
SpartaLabs
June 17, 2026
PT-141 (Bremelanotide): A Research Overview
A research-library overview of PT-141 (bremelanotide) — chemistry, melanocortin receptor pharmacology, FDA approval as Vyleesi, and discovery history. Educational reference.
pt-141bremelanotidemelanocortin
SpartaLabs
June 17, 2026
PT-141 (Bremelanotide): Mechanism of Action
A research-library summary of bremelanotide's reported mechanism of action — melanocortin receptor targets, CNS signaling pathways, and downstream neurological effects. Educational reference.
pt-141bremelanotidemelanocortin
SpartaLabs
June 17, 2026
PT-141 (Bremelanotide): Discovery and Regulatory History
A research-library timeline of PT-141 (bremelanotide) — from melanocortin peptide chemistry at the University of Arizona through Palatin Technologies development and the 2019 FDA approval of Vyleesi. Educational reference.
pt-141bremelanotidemelanocortin